Supplementary Methods HPLC chromatography. HPLC analysis was performed on a Grace Vydac C-18 column (100 × 4.6 mm) at a flow rate of 1 mL/min. Flow A was 0.1% TFA in water and flow B was 0.1% TFA in acetonitrile. The elution method for analytical HPLC started with 70% A for 3 min, arrived at 30% A in another 18 min, held at 30% A for 3 min, and finally returned to 70% A over one min. The elution profile was monitored by UV absorbance at 254 and 695 nm. Semi-preparative HPLC separation was performed on a Grace Vydac C-18 column (250 × 22 mm) at 23 mL/min.
Synthesis. 3-(3-(1-Carboxy-2-hydroxyethylamino)-3-oxopropyl)-1,1,2-trimethyl-1H-benzo[e]indolium (2): A mixture of compound 1 (362 mg, 1 mmol), DIC (253 mg, 2 mmol) and HOBT (135 mg, 1 mmol) in DMF (30 mL) was stirred at room temperature for 20 min and then cooled to 0 °C. A solution of O-tert-butyl-L-serine-tert-butyl ester hydrochloride (279 mg, 1.1 mmol) in DMF (10 mL) was added dropwise to the compound 1 mixture. Upon completion of the addition, the resulting reaction mixture was allowed to warm to room temperature and stirred for another 2 h. The reaction solution was concentrated under by vacuum, and the crude product was purified with silica gel column chromatography using a 1: 3-(3-(1-Carboxy-2-benzyloxy(hydroxy)phosphoryloxy-ethylamino)-3-oxopropyl)-1,1,2-trimethyl-1H-benzo[e]indolium (4) on solid support: Br-Wang resin (0.3 mmol; 1.4 mmol/g) was preswelled in DCM for 40 min, followed by washing with DCM and DMF. A solution of N-α-Fmoc-Obenzyl-L-phosphoserine (448 mg, 0.9 mmol), DIEA (116mg, 0.9 mmol) and CsI (23.4 mg, 0.09 mmol) in DMF was stirred at room temperature for overnight. The resulting resin was washed with DMF, DCM and hexane to ensure all the reagent, salt and excess amine acids were removed. The resin was dried in vacuum and lyophilized overnight. Fmoc loading of 0.71 mmol/g was determined by absorption spectroscopy. Cypate-diserine (LS456), cypate-monophospho-diserine (LS455) and cypate-diphosphodiserine(LS631): A mixture of N-(5-anilino-2,4-pentadienylidene) aniline hydrochloride (1.9 mg, 6.5 µmol) and DIEA (1.7 mg, 13 µmol) in DCM (0.5 mL) was treated with a solution of acetic anhydride (0.8 mg, 7.8 µmol) in DCM (0.5 mL) at 0°C. The resulting clear solution was stirred at room temperature for 1 h. The solvent was removed and replaced with methanol (0.5 mL). The solution was added to a mixture of 3 (2.4 mg, 6.6 µmol), 5 (2.9 mg, 6.5 µmol), and sodium acetate (2.6 mg, 32 µmol) in methanol (1 mL MS/MS mass spectrometry methods. The phosphorylation products were extracted from the gel and analyzed by MS/MS according to the method described by Steinberg et al 1 . Briefly, the bands with the probes were cut from SDS-PAGE gel and washed twice with 50% acetonitrile in deionized water for 20 min and 100% acetonitrile and tried. Peptides and their binding target were subsequently extracted with 50 µL of 10% acetonitrile and 5% TFA for 30 min followed by another 50 µL of 10% acetonitrile and 5% TFA in deionized water for 60 min. All supernatants were dried and dissolved in 15 µL of 10% acetonitrile and 0.1% TFA for MS/MS analysis using TSQ Vantage Mass Spectrometer (Thermo Scientific, San Jose, CA) to identify the phosphorylation products.
Supplementary Figures
The supplementary figures for the study are shown below.
Supplementary Figure 1. Stability testing in vitro.
Analysis of the spectral profiles of LS455 (a) and LS456 (b) in tris saline buffer (TSB; pH 7.4; left panels of a and b) and insulin dissolved in TSB (pH 7.4; right panels of a and b) in cell-free system at Ex/Em=620/645-900 nm in 30 ˚C. Although some fluctuations were noted in the spectral profile of LS455 at the early time points, the ratios of the 700/800 nm emissions for LS455 and 456 were stable over time in both TSB and 150 nM insulin in TSB (50 mM Tris; 150 mM NaCl; pH=7.4) for 4 h. The minor peak at 650 nm may be caused by the bleed through of the 620 nm excitation light 
